While T lymphocytes including γδ T cells in tumor patients are often suggested to be in an activated state, we examined whether the release of gal-3 differs in short-term activated T cells (Figure 5A) in comparison to resting T cells (Figure 2C). This evidence concerns the gene LGALS3 and neoplasm.